$CRCL stock rose 7% this week, according to our price data from Polygon.
It has been the 44th most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.
Here is what we see in our data on $CRCL (you can track the company live on Quiver's $CRCL stock page):
$CRCL Insider Trading Activity
$CRCL insiders have traded $CRCL stock on the open market 226 times in the past 6 months. Of those trades, 0 have been purchases and 226 have been sales.
Here’s a breakdown of recent trading of $CRCL stock by insiders over the last 6 months:
- PATRICK SEAN NEVILLE has made 0 purchases and 23 sales selling 1,359,396 shares for an estimated $112,623,760.
- NIKHIL CHANDHOK (Chief Product & Tech. Officer) has made 0 purchases and 12 sales selling 609,735 shares for an estimated $45,243,022.
- HEATH TARBERT (President) has made 0 purchases and 34 sales selling 245,694 shares for an estimated $23,976,008.
- M MICHELE BURNS has made 0 purchases and 14 sales selling 176,668 shares for an estimated $17,626,770.
- JEREMY ALLAIRE (Chairman and CEO) has made 0 purchases and 115 sales selling 202,417 shares for an estimated $14,614,137.
- JEREMY FOX-GEEN (Chief Financial Officer) has made 0 purchases and 9 sales selling 98,818 shares for an estimated $8,912,319.
- HOSSEIN RAZZAGHI (Chief Commercial Officer) has made 0 purchases and 4 sales selling 81,402 shares for an estimated $7,269,726.
- RAJEEV V DATE has made 0 purchases and 6 sales selling 33,438 shares for an estimated $3,088,076.
- DANITA K OSTLING has made 0 purchases and 3 sales selling 23,700 shares for an estimated $1,611,872.
- TAMARA L SCHULZ (Chief Accounting Officer) has made 0 purchases and 6 sales selling 7,311 shares for an estimated $627,363.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$CRCL Hedge Fund Activity
We have seen 376 institutional investors add shares of $CRCL stock to their portfolio, and 286 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ACCEL XI ASSOCIATES L.L.C. removed 5,569,648 shares (-86.0%) from their portfolio in Q2 2026, for an estimated $348,827,054
- MORGAN STANLEY added 3,334,224 shares (+66.9%) to their portfolio in Q2 2026, for an estimated $208,822,449
- BLACKROCK, INC. added 3,306,179 shares (+65.4%) to their portfolio in Q2 2026, for an estimated $207,065,990
- MARSHALL WACE, LLP removed 2,899,204 shares (-50.0%) from their portfolio in Q2 2026, for an estimated $181,577,146
- JPMORGAN CHASE & CO added 2,656,085 shares (+inf%) to their portfolio in Q2 2026, for an estimated $166,350,603
- JANE STREET GROUP, LLC added 1,940,722 shares (+1162.4%) to their portfolio in Q1 2026, for an estimated $185,164,286
- UBS GROUP AG added 1,866,907 shares (+81.9%) to their portfolio in Q2 2026, for an estimated $116,924,385
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$CRCL Price Targets
Multiple analysts have issued price targets for $CRCL recently. We have seen 11 analysts offer price targets for $CRCL in the last 6 months, with a median target of $138.0.
Here are some recent targets:
- James Yaro from Goldman Sachs set a target price of $96.0 on 07/02/2026
- Ed Engel from Compass Point set a target price of $55.0 on 07/01/2026
- James Friedman from Susquehanna set a target price of $69.0 on 07/01/2026
- Dan Dolev from Mizuho set a target price of $85.0 on 06/05/2026
- James Faucette from Morgan Stanley set a target price of $106.0 on 05/19/2026
- Mike Colonnese from HC Wainwright & Co. set a target price of $150.0 on 05/18/2026
- John Todaro from Needham set a target price of $150.0 on 05/12/2026
You can track data on $CRCL on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
